13 March 2023 LungLife AI, Inc. (the “Company” or “LungLife”) Statement re. Silicon Valley Bank LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, is aware of media reports indicating the closure of Silicon Valley Bank (“SVB”). The Company does not hold any cash at SVB, nor does it have a […]
7 March 2023 LungLife AI, Inc. (the “Company” or “LungLife”) Nodule evaluation using LungLB® projected to be cost-effective in US healthcare system Data strongly support payor coverage of indeterminate lung nodule evaluation using LungLB® in peer-reviewed publication in the Journal of Medical Economics. LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung […]
LungLife AI licensure/accreditation information posted here.